Skip to Content

Clinical Trials Search Results

Showing 1-10 of 37

Sorted By:

  • ACCRU RU011201I

    A Randomized Phase III Trial of Eribulin Compared to Standard Weekly Paclitaxel as First- or Second-Line Therapy for Locally Recurrent or Metastatic Breast Cancer.

  • Alliance A011202

    A randomized phase iii trial evaluating the role of axillary lymph node dissection in breast cancer patients (ct1-3 n1) who have positive sentinel lymph node disease after neoadjuvant chemotherapy.

  • Alliance A031201

    Phrase III trial of Enzalutamide versus Enzalutamide, Abiraterone, and Prednisone for Castration Resistant Metastatic Prostate Cancer

  • Astex AT13397-05

    A Study of HSP90 Inhibitor AT13387 Alone and in Combination with Crizotinib in the Treatment of Non-small Cell Lung Cancer (NSCLC)

  • BMS CA209-118

    Lung Cancer Molecular Profiling & Clinical Outcomes in U.S. Community Oncology Practices

  • BMS CA209-118

    Lung Cancer Molecular Profiling & Clinical Outcomes in U.S. Community Oncology Practices

  • BMS CA209-153

    A Phase IIIb/IV Safety Trial of Nivolumab (BMS- 936558) in Subjects with Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Systemic Regimen

  • CALGB 50904

    A Randomized Phase II Trial of Ofatumumab and Bendamustine vs. Ofatumumab, Bortezomib, and Bendamustine in Patients with Untreated Follicular Lymphoma

  • CALGB 80702

    A Phase III Trial of 6 Versus 12 Treatments of Adjuvant FOLFOX Plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer

  • Celgene ABI-007-NSCL-003

    A Phase III, randomized, open-label, cross-over, multi-center, safety and efficacy study to evaluate nab-paclitaxel (Abraxane) as maintenance treatment after induction with nab-paclitaxel plus carboplatin in subjects with squamous cell non-small cell lung cancer (NSCLC)

Page of 4, showing trials 1-10 of 37

Also in this Section